small molecule

INDOCYANINE GREEN

INDOCYANINE GREEN

Loss of exclusivityJanuary 2027FDA regulatory exclusivity expiry
CompanyZYDUS LIFESCIENCES GLOBAL FZE

Drug detail

Brand nameINDOCYANINE GREEN
Active ingredientINDOCYANINE GREEN
Strength25MG/VIAL
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalAugust 2026
Marketing statusRX

Regulatory exclusivity

CodeExpires
CGTJanuary 2027

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.